Concepedia

Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.

Ying Liu, Z P Ren, Long Yuan, Shuning Xu, Zhihua Yao, Lei Qiao, Ke Li

PubMed · 2016 · 59 citations · 14 references

Concepts

Abstract

=0.204). The first-line chemotherapy of paclitaxel plus cisplatin had better median progression-free survival than 5-fluorouracil plus cisplatin in patients with advanced esophageal squamous cell carcinoma with tolerable toxicities.

References

14

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

H. Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology · 2014 · 2.5K citations

, , +13

Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease

C. Mariette, Jean‐Michel Balon, Guillaune Piessen et al. · Cancer · 2003 · 403 citations

, , +17

Epidemiology of gastrointestinal and liver tumors.

László Herszényi, Zsolt Tulassay · PubMed · 2010 · 387 citations

, , +16

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

Harry Bleiberg, Thierry Conroy, B Paillot et al. · European Journal of Cancer · 1997 · 348 citations

, , +11

Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy

Satoru Nakagawa, Tatsuo Kanda, Shin‐ichi Kosugi et al. · Journal of the American College of Surgeons · 2004 · 330 citations

, , +10